相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Proteolytic, lipidergic and polysaccharide molecular recognition shape innate responses to house dust mite allergens
Alain Jacquet et al.
ALLERGY (2020)
Infection and atherosclerosis: TLR-dependent pathways
Bowei Li et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Protection of Sacubitril/Valsartan against Pathological Cardiac Remodeling by Inhibiting the NLRP3 Inflammasome after Relief of Pressure Overload in Mice
Xueling Li et al.
CARDIOVASCULAR DRUGS AND THERAPY (2020)
Early Moderate Intensity Aerobic Exercise Intervention Prevents Doxorubicin-caused Cardiac Dysfunction through Inhibition of Cardiac Fibrosis and Inflammation
Hsin-Lun Yang et al.
CANCERS (2020)
ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020
Elliott Lilley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction Rationale and Design of the LIFE Trial
Douglas L. Mann et al.
JACC-HEART FAILURE (2020)
Osteocrin attenuates inflammation, oxidative stress, apoptosis, and cardiac dysfunction in doxorubicin-induced cardiotoxicity
Can Hu et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
The ARRIVE guidelines 2.0: updated guidelines for reporting animal research
Nathalie Percie du Sert et al.
JOURNAL OF PHYSIOLOGY-LONDON (2020)
TLR2 and TLR3 expression as a biomarker for the risk of doxorubicininduced heart failure
Shao Liang et al.
TOXICOLOGY LETTERS (2018)
Bioactive Signaling in Next-Generation Pharmacotherapies for Heart Failure A Review
Kelsie E. Oatmen et al.
JAMA CARDIOLOGY (2018)
Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides
Emilia D'Elia et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
LCZ696 improves cardiac function via alleviating Drpl-mediated mitochondrial dysfunction in mice with doxorubicin-induced dilated cardiomyopathy
Yan Xia et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
Customized laboratory TLR4 and TLR2 detection method from peripheral human blood for early detection of doxorubicin-induced cardiotoxicity
A. L. Pop-Moldovan et al.
CANCER GENE THERAPY (2017)
TLRs, future potential therapeutic targets for RA
Hatem A. Elshabrawy et al.
AUTOIMMUNITY REVIEWS (2017)
LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice
Yasunori Suematsu et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Clyde W. Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Insights into Soluble Toll-Like Receptor 2 as a Downregulator of Virally Induced Inflammation
Bethany M. Henrick et al.
FRONTIERS IN IMMUNOLOGY (2016)
Dual Angiotensin Receptor and Neprilysin Inhibition with Sacubitril/Valsartan in Chronic Systolic Heart Failure: Understanding the New PARADIGM
Matthew P. Lillyblad
ANNALS OF PHARMACOTHERAPY (2015)
Prevention of Anthracycline-Induced Cardiotoxicity
Pimprapa Vejpongsa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
Oktay Tacar et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
An overview of the Amber biomolecular simulation package
Romelia Salomon-Ferrer et al.
WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2013)
Doxorubicin Cardiomyopathy
Kanu Chatterjee et al.
CARDIOLOGY (2010)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Toll-like receptor-4 deficiency attenuates doxorubicin-induced cardiomyopathy in mice
Alexander Riad et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Congestive heart failure in patients treated with doxorubicin - A retrospective analysis of three trials
SM Swain et al.
CANCER (2003)
分享论文
